Global Peripheral Neuropathy Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 119 pages | ID: G0C7F852A32GEN
GlobalInfoResearch

Abstracts

Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology.

SCOPE OF THE REPORT:

The global Peripheral Neuropathy Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Peripheral Neuropathy Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Peripheral Neuropathy Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Peripheral Neuropathy Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Eli Lilly
• Johnson & Johnson
• Novartis
• Pfizer
• Aptinyx
• Regenacy Pharmaceuticals
• TEVA Pharmaceutical Industries
• Immune Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Calcium Channel ?2-delta Ligands
• Antidepressants
• Opioids
• Others

Market Segment by Applications, can be divided into

• Platinum Agents
• Taxanes
• Vinca Alkaloids
• Others

Contents

1 PERIPHERAL NEUROPATHY TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Peripheral Neuropathy Treatment
1.2 Classification of Peripheral Neuropathy Treatment by Types
  1.2.1 Global Peripheral Neuropathy Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Peripheral Neuropathy Treatment Revenue Market Share by Types in 2017
  1.2.3 Calcium Channel ?2-delta Ligands
  1.2.4 Antidepressants
  1.2.5 Opioids
  1.2.6 Others
1.3 Global Peripheral Neuropathy Treatment Market by Application
  1.3.1 Global Peripheral Neuropathy Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Platinum Agents
  1.3.3 Taxanes
  1.3.4 Vinca Alkaloids
  1.3.5 Others
1.4 Global Peripheral Neuropathy Treatment Market by Regions
  1.4.1 Global Peripheral Neuropathy Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Peripheral Neuropathy Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Peripheral Neuropathy Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Peripheral Neuropathy Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Peripheral Neuropathy Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Peripheral Neuropathy Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Peripheral Neuropathy Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Eli Lilly
  2.1.1 Business Overview
  2.1.2 Peripheral Neuropathy Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Eli Lilly Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
  2.2.1 Business Overview
  2.2.2 Peripheral Neuropathy Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Johnson & Johnson Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
  2.3.1 Business Overview
  2.3.2 Peripheral Neuropathy Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Novartis Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Peripheral Neuropathy Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Pfizer Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Aptinyx
  2.5.1 Business Overview
  2.5.2 Peripheral Neuropathy Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Aptinyx Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Regenacy Pharmaceuticals
  2.6.1 Business Overview
  2.6.2 Peripheral Neuropathy Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 TEVA Pharmaceutical Industries
  2.7.1 Business Overview
  2.7.2 Peripheral Neuropathy Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Immune Pharmaceuticals
  2.8.1 Business Overview
  2.8.2 Peripheral Neuropathy Treatment Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Immune Pharmaceuticals Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PERIPHERAL NEUROPATHY TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Peripheral Neuropathy Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Peripheral Neuropathy Treatment Players Market Share
  3.2.2 Top 10 Peripheral Neuropathy Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL PERIPHERAL NEUROPATHY TREATMENT MARKET SIZE BY REGIONS

4.1 Global Peripheral Neuropathy Treatment Revenue and Market Share by Regions
4.2 North America Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PERIPHERAL NEUROPATHY TREATMENT REVENUE BY COUNTRIES

5.1 North America Peripheral Neuropathy Treatment Revenue by Countries (2013-2018)
5.2 USA Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE PERIPHERAL NEUROPATHY TREATMENT REVENUE BY COUNTRIES

6.1 Europe Peripheral Neuropathy Treatment Revenue by Countries (2013-2018)
6.2 Germany Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
6.4 France Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC PERIPHERAL NEUROPATHY TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Peripheral Neuropathy Treatment Revenue by Countries (2013-2018)
7.2 China Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
7.5 India Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA PERIPHERAL NEUROPATHY TREATMENT REVENUE BY COUNTRIES

8.1 South America Peripheral Neuropathy Treatment Revenue by Countries (2013-2018)
8.2 Brazil Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE PERIPHERAL NEUROPATHY TREATMENT BY COUNTRIES

9.1 Middle East and Africa Peripheral Neuropathy Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL PERIPHERAL NEUROPATHY TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Peripheral Neuropathy Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Peripheral Neuropathy Treatment Market Forecast by Type (2018-2023)
10.3 Calcium Channel ?2-delta Ligands Revenue Growth Rate (2013-2023)
10.4 Antidepressants Revenue Growth Rate (2013-2023)
10.5 Opioids Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)

11 GLOBAL PERIPHERAL NEUROPATHY TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Peripheral Neuropathy Treatment Revenue Market Share by Application (2013-2018)
11.2 Peripheral Neuropathy Treatment Market Forecast by Application (2018-2023)
11.3 Platinum Agents Revenue Growth (2013-2018)
11.4 Taxanes Revenue Growth (2013-2018)
11.5 Vinca Alkaloids Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)

12 GLOBAL PERIPHERAL NEUROPATHY TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Peripheral Neuropathy Treatment Market Size Forecast (2018-2023)
12.2 Global Peripheral Neuropathy Treatment Market Forecast by Regions (2018-2023)
12.3 North America Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)
12.6 South America Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Peripheral Neuropathy Treatment Picture
Table Product Specifications of Peripheral Neuropathy Treatment
Table Global Peripheral Neuropathy Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Peripheral Neuropathy Treatment Revenue Market Share by Types in 2017
Figure Calcium Channel ?2-delta Ligands Picture
Figure Antidepressants Picture
Figure Opioids Picture
Figure Others Picture
Table Global Peripheral Neuropathy Treatment Revenue (Million USD) by Application (2013-2023)
Figure Peripheral Neuropathy Treatment Revenue Market Share by Applications in 2017
Figure Platinum Agents Picture
Figure Taxanes Picture
Figure Vinca Alkaloids Picture
Figure Others Picture
Table Global Market Peripheral Neuropathy Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Peripheral Neuropathy Treatment Type and Applications
Table Eli Lilly Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Peripheral Neuropathy Treatment Type and Applications
Table Johnson & Johnson Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Peripheral Neuropathy Treatment Type and Applications
Table Novartis Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Peripheral Neuropathy Treatment Type and Applications
Table Pfizer Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Aptinyx Basic Information, Manufacturing Base and Competitors
Table Aptinyx Peripheral Neuropathy Treatment Type and Applications
Table Aptinyx Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Regenacy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Type and Applications
Table Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table TEVA Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Type and Applications
Table TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Immune Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Immune Pharmaceuticals Peripheral Neuropathy Treatment Type and Applications
Table Immune Pharmaceuticals Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Peripheral Neuropathy Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Peripheral Neuropathy Treatment Revenue Share by Players (2013-2018)
Figure Global Peripheral Neuropathy Treatment Revenue Share by Players in 2016
Figure Global Peripheral Neuropathy Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Peripheral Neuropathy Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Peripheral Neuropathy Treatment Revenue Market Share in 2017
Figure Global Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Peripheral Neuropathy Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Peripheral Neuropathy Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Peripheral Neuropathy Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Peripheral Neuropathy Treatment Revenue Market Share by Regions in 2017
Figure North America Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure South America Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Table North America Peripheral Neuropathy Treatment Revenue by Countries (2013-2018)
Table North America Peripheral Neuropathy Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Peripheral Neuropathy Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2017
Figure USA Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Table Europe Peripheral Neuropathy Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Peripheral Neuropathy Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2017
Figure Germany Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure UK Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure France Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Peripheral Neuropathy Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Peripheral Neuropathy Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2017
Figure China Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure India Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Table South America Peripheral Neuropathy Treatment Revenue by Countries (2013-2018)
Table South America Peripheral Neuropathy Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Peripheral Neuropathy Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2017
Figure Brazil Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Peripheral Neuropathy Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Peripheral Neuropathy Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peripheral Neuropathy Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Peripheral Neuropathy Treatment Revenue and Growth Rate (2013-2018)
Table Global Peripheral Neuropathy Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Peripheral Neuropathy Treatment Revenue Share by Type (2013-2018)
Figure Global Peripheral Neuropathy Treatment Revenue Share by Type (2013-2018)
Figure Global Peripheral Neuropathy Treatment Revenue Share by Type in 2017
Table Global Peripheral Neuropathy Treatment Revenue Forecast by Type (2018-2023)
Figure Global Peripheral Neuropathy Treatment Market Share Forecast by Type (2018-2023)
Figure Global Calcium Channel ?2-delta Ligands Revenue Growth Rate (2013-2018)
Figure Global Antidepressants Revenue Growth Rate (2013-2018)
Figure Global Opioids Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Peripheral Neuropathy Treatment Revenue by Application (2013-2018)
Table Global Peripheral Neuropathy Treatment Revenue Share by Application (2013-2018)
Figure Global Peripheral Neuropathy Treatment Revenue Share by Application (2013-2018)
Figure Global Peripheral Neuropathy Treatment Revenue Share by Application in 2017
Table Global Peripheral Neuropathy Treatment Revenue Forecast by Application (2018-2023)
Figure Global Peripheral Neuropathy Treatment Market Share Forecast by Application (2018-2023)
Figure Global Platinum Agents Revenue Growth Rate (2013-2018)
Figure Global Taxanes Revenue Growth Rate (2013-2018)
Figure Global Vinca Alkaloids Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Peripheral Neuropathy Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Peripheral Neuropathy Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)
Figure Europe Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)
Figure South America Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Peripheral Neuropathy Treatment Revenue Market Forecast (2018-2023)